Flow cytometry is a vital technique employed for screening cells within a mixed cell population, offering applications in cell sorting, counting, protein analysis, and engineering. It facilitates the analysis of cell surface and intracellular molecule expression, identification and characterization of different cell types in a heterogeneous population, assessment of subpopulation purity, and measurement of cell size and volume. Flow cytometry enables the simultaneous examination of multiple parameters for individual cells by utilizing lasers to generate light, which is then detected and converted into signals for analysis and measurement.
According to Data Bridge Market Research, the Flow Cytometry Market accounted for USD 1,068.66 million in 2022, and expected to reach USD 2,395.04 million by 2030. The market is expected to grow with a CAGR of 10.7% in the forecast period of 2023 to 2030.
“Rising prevalence of chronic diseases”
The rising prevalence and incidence of chronic diseases are expected to propel the growth of the cytometry devices market. Particularly, the Asia-Pacific region is witnessing a surge in market growth due to increased investments by companies in research and development activities. This has created a substantial demand for innovative and accurate techniques to diagnose diseases promptly. Consequently, there is a growing emphasis on advancements in cytometry devices to meet the evolving diagnostic needs of the region.
What restraints the growth of the flow cytometry market?
“High cost of flow cytometry instruments”
Flow cytometers are available in various sizes and configurations, with benchtop instruments being the most prevalent and very expensive. These instruments are made of expensive materials which further limits their demand in the market. They are designed to address specific requirements such as customized separations, cell/particle sorting, and exploratory cell analysis. Therefore, the maintenance cost is also very high which restraints the market’s growth.
Segmentation: Asia-Pacific Flow Cytometry Market
The flow cytometry market is segmented on the basis of product, technology, application, end user, and distribution channel.
- On the basis of product, the flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.
- On the basis of technology, the flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.
- On the basis of application, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications.
- On the basis of end user, the flow cytometry market is segmented into academic and research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.
- On the basis of the distribution channel, the flow cytometry market is segmented into retail sales and direct tenders.
Regional Insights: Japan is expected to dominate the Flow Cytometry Market
Japan is expected to dominate the Asia-Pacific flow cytometry market due to the growing research and development activities for disease diagnosis and prevention in this country. They are dominating the flow cytometry market in terms of market share and market revenue and will continue to flourish their dominance during the forecast period.
To know more about the study visit, https://www.databridgemarketresearch.com/de/reports/asia-pacific-flow-cytometry-market
Recent Developments in Flow Cytometry Market
- In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.
The Prominent Key Players Operating in the Flow Cytometry Market Include:
- Thermo Fisher Scientific Inc. (U.S.)
- BD (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Sysmex Corporation (Japan)
- Coherent Corp. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Cytek Biosciences (U.S.)
- bioMérieux SA (France)
- Q2 Solutions (U.S.)
- Cytonome/ST, LLC (U.S.)
- Merck KGaA (Germany)
- Sony Biotechnology Inc. (U.S.)
- Cell Signaling Technology, Inc. (U.S.)
- Enzo Biochem Inc. (U.S.)
- Takara Bio Inc. (Japan)
- CellKraft Biotech Pvt. Ltd. (India)
- IKEDA SCIENTIFIC Co., Ltd. (Japan)
- Apogee Flow Systems Ltd. (U.K.)
- Sartorius AG (Germany)
- Bay bioscience Co., Ltd. (Japan)
- Elabscience Biotechnology Inc. (U.S.)
- Miltenyi Biotec (Germany)
- CytoBuoy b.v. (Netherlands)
- ORFLO Technologies (U.S.)
- BioLegend, Inc. (U.S.)
- NeoGenomics Laboratories (U.S.)
- Nexcelom Bioscience LLC (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of flow cytometry market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Asia-Pacific Flow Cytometry Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Asia-Pacific vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
